Omada Health (OMDA) Q4 FY25 Earnings Call

Strong 2025 profitability and product optionality contrast with a prudent 22% 2026 revenue-growth guide.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-06
Length65 minutes
EPS$0.08
Revenue$68.0M
Revenue consensus$69.7M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All OMDA earnings ยท Back to OMDA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.